Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol

Hodis, Howard N., Mack, Wendy J., Henderson, Victor W., Shoupe, Donna, Budoff, Matthew J., Hwang-Levine, Juliana, Li, Yanjie, Feng, Mei, Dustin, Laurie, Kono, Naoko, Stanczyk, Frank Z., Selzer, Robert H., Azen, Stanley P.·2016·New England Journal of Medicine
DOI 10.1056/nejmoa1505241

Cited by (775)

Items 701–775 of 775

  1. Gender-affirming care in adolescents and young adults with cardiovascular conditions: clinical considerations in a limited evidence landscape
    Thomas Agostini, Eyal Sagiv, Juanita K. Hodax, Andrew R. Pistner, Jason F. Deen · 2025 · Cardiology in the Young
  2. Menopause Step-by-Step: must-know studies
    Cynthia A. Stuenkel · 2025 · Menopause The Journal of The North American Menopause Society
  3. Navigating dual risks: Ovarian cancer prevention and cardiovascular health in patients with hereditary cancer syndromes
    Laura A. Keenahan, Muhammad Danyal Ahsan, Alicia Mecklai, Melissa Kristen Frey · 2025 · Gynecologic Oncology Reports
  4. Le retour du traitement hormonal de ménopause
    Florence Trémollières, Anna Gosset · 2025 · Revue du Rhumatisme
  5. Hormone Replacement Therapy for Cardiovascular Prevention: Hope or Hype?
    Shoomena Anil, Vassilios S. Vassiliou · 2025 · British Journal of Hospital Medicine
  6. The role of hormone receptors in breast cancer: New opportunities for treatment and prevention
    Prachi Parvatikar, Suman Kumar Ray, Manohar Suresh Kugaji, Anitha Sriram, Pankaj Kumar Singh · 2025 · Elsevier eBooks
  7. Sex Differences in the Protective Effect of Brain Volume: Age Attenuates Protection in Females
    Javier Gomez-Farias, Ngoc Mai Le, Joseph N. Samaha, Bruna Kfoury, Hussain Azeem, Ritesh Bajaj, Shikha Tripathi, Shayan Shams, Luca Giancardo, Eunyoung Lee et al. · 2025 · medRxiv
  8. I treat menopause and its symptoms, and hormone replacement therapy can help – here’s the science behind the FDA’s decision to remove warnings
    Genevieve Hofmann · 2025
  9. Relationship between Obesity Phenotype and Hormonal Disorders
    Alina Yu. Babenko · 2025 · Journal of Evolutionary Biochemistry and Physiology
  10. Estrogen therapies enhance mammary carcinogenesis in aging gerbil females under endocrine disruption
    Thalles Fernando Rocha Ruiz, Stella Bicalho Silva, Vitor Grigio, Paula Rahal, Marília de Freitas Calmon, Patrícia Simone Leite Vilamaior, Ellen Cristina Rivas Leonel, Sebastião Roberto Taboga · 2025 · Molecular and Cellular Endocrinology
  11. Additional file 1 of Role of OAS gene family in COVID-19 induced heart failure
    Gao, Li-Juan, He, Zhong-Mei, Li, Yi-Ying, Yang, Rui-Rui, Yan, Min, Xuan Shang, Cao, Ji-Min · 2024 · Figshare
  12. Additional file 3 of Role of OAS gene family in COVID-19 induced heart failure
    Gao, Li-Juan, He, Zhong-Mei, Li, Yi-Ying, Yang, Rui-Rui, Yan, Min, Xuan Shang, Cao, Ji-Min · 2024 · Figshare
  13. Additional file 2 of Role of OAS gene family in COVID-19 induced heart failure
    Lijuan Gao, He, Zhong-Mei, Li, Yi-Ying, Yang, Rui-Rui, Yan, Min, Xuan Shang, Cao, Ji-Min · 2024 · Figshare
  14. Gender differences in lipid metabolism
    Jonathan Giang, Louay Saem Aldaher, Henrique C. Ferreira · 2025 · Elsevier eBooks
  15. Metabolic Changes and Menopause
    Svetlana Spremović-Radjenović · 2025 · Science, Art and Religion.
  16. Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP, RSMSI, RAGG
    E.V. Shlyakhto, Ivan Ivanovich Dedov, Vladimir Nikolaevich Serov, G. T. Sukhikh, G. P. Arutyunov, I. A. Suchkov, Oksana M. Drapkina, Olga N. Tkacheva, Yа. A. Orlova, I.A. Baranov et al. · 2025 · Kardiologiia
  17. Ménopause, traitement hormonal et risque cardiovasculaire
    Geneviève Plu‐Bureau, Iphigénie Cavadias, Brigitte Raccah-Tebeka, Manon Jouffroy, Claire Mounier‐Véhier · 2025 · médecine/sciences
  18. Renal Hematoma after Ureteroscopy and Retrograde Intrarenal Surgery: Incidence, Risk Factors, and Management Strategies—Application of the REVEAL Framework from EAU Endourology
    Ali Talyshinskii, Robert M. Geraghty, Arianna Pischetola, Bhaskar Kumar Somani · 2026 · Journal of Endourology
  19. Hormone Replacement Therapy and Cardiovascular Outcomes by Race and Ethnicity
    Spencer Flynn, Amier Haidar, Icy Y. Liang, Karol E. Watson, Tamara B. Horwich, Preethi Srikanthan · 2026 · JACC Advances
  20. Engineered Microfluidic Organoid Systems: New Paradigms for Menopause Mechanism Research and Personalized Medicine
    Qianyi Zhang, He Huang, Hongliang Dong, Qiang Ma, Hongyan Jin · 2026 · Advanced Materials Technologies
  21. Physiological Mechanisms and Intervention Strategies for the Increased Cardiovascular Risk in Perimenopausal Women
    Jiayi Chen · 2026 · International Journal of Social Sciences and Public Administration
  22. A review of estrogens used in menopausal hormone therapy
    Amythis Soltani, Amy J. Voedisch · 2026 · Current Opinion in Obstetrics & Gynecology
  23. Neurological diseases: Sex and gender differences in stroke, migraine, and Alzheimer’s dementia
    Tracy E. Madsen, Stephanie C. McClure · 2026 · Elsevier eBooks
  24. Hormone Therapy Timing and Chronic Disease Incidence in Primary Ovarian Insufficiency: A National Cohort Study
    Hyun Joo Lee, Eun Hee Yu, Sul Lee, Seung Chul Kim, Jong Kil Joo · 2026 · BJOG An International Journal of Obstetrics & Gynaecology
  25. Sex-specific lymphatic responses to estrogen shape atherosclerosis in high-risk mice
    Mona Mesples, Elizabeth Lacroix, Nolwenn Tessier, Maya Farhat, Andreea Milasan, Sara Babran, Cristina Fernandez, Tally Latendresse, Justin Benoit, Valérie Long et al. · 2026 · Frontiers in Cardiovascular Medicine
  26. Ocular microvascular changes in hypoestrogenism: an OCT/OCTA systematic review and meta-analysis
    Inaam Chattha, Xiang Ji, YiFan Kang, Michael Balas, Marko M. Popovic, Rajeev Muni, Radha P. Kohly · 2026 · Graefe s Archive for Clinical and Experimental Ophthalmology
  27. Association entre les facteurs hormonaux et reproductifs et le risque d’hypertension artérielle dans la cohorte prospective E3N
    Anne‐Laure Madika · 2022 · theses.fr (ABES)
  28. Hot flashes, cold feet: a cautious embrace of regulatory reform
    Raya Kheirbek, Stephen N Davis · 2026 · The Journals of Gerontology Series A
  29. Spontaneous Premature Ovarian Insufficiency: Methods Under Research for Infertility Treatment
    Ranko M. Kutlesic, Marija S. Kutlesic, Jelena Milošević, Predrag Vukomanović, Danka Mostić-Stanišić · 2026 · Journal of Clinical Medicine
  30. Beyond the conventional risk factors in the management of atherosclerosis in women: a call to action for careful consideration of obesity and inflammation
    Mirvat A. Alasnag, Antonia Sambola, Izabella Uchmanowicz, Marta Kałużna, Pierre François Sabouret, Laura Serrano, Valeria Paradies, Biljana J Parapid, Shrilla Banerjee, Anne Bachelot et al. · 2026 · European Heart Journal Open
  31. Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG
    E. V. Shlyakhto, Ivan Ivanovich Dedov, Vladimir Nikolaevich Serov, G. T. Sukhikh, G. P. Arutyunov, I. A. Suchkov, Oksana M. Drapkina, O N Tkacheva, Ya. A. Orlova, I.A. Baranov et al. · 2026 · Bulletin of Reproductive Health
  32. Swinging Pendulum of Hormone Therapy: A Historical Perspective
    Renee N. Rivas, Valerie A. Flores, JoAnn E. Manson · 2026 · Springer eBooks
  33. Menopausal Hormone Therapy and Cardiovascular Disease
    Nancy Safwan, Mariam Saadedine, Stephanie S. Faubion · 2026 · Springer eBooks
  34. Assessment of Cardiovascular Disease Risk Across the Lifespan
    Danielle N. Tapp, Denaja Haygood, Paxson Tipler, Andreas Tzoumas, Odayme Quesada · 2026 · Springer eBooks
  35. MENOPAUSAL HORMONE THERAPY AND DEMENTIA RISK: AN INTEGRATED NEUROVASCULAR AND PRECISION MEDICINE PERSPECTIVE
    Natalia Stanek, Aleksandra Jagiełło, Piotr Pietrzyk, Beata Szreder, Patrycja Krawczyk, Joanna Ślusarczyk, Maja Łapaj, Zuzanna Noweta, Milena Lewicka, Tamara Chodań · 2026 · International Journal of Innovative Technologies in Social Science
  36. Real-world study on the effectiveness and breast safety analysis of hormone replacement therapy during menopause
    Yingxia Wang, Yaqin Liu, Jing Zeng, Mengyi Wang, Yuhuan Li, Yinglan Wu, Jie Gao, Xia Chen · 2026 · Frontiers in Medicine
  37. Primary prevention of coronary heart disease in women
    John Stevenson · 2026 · Post Reproductive Health
  38. The use of menopause hormone therapy in borderline ovarian tumor survivors: a systematic review and meta-analysis
    Javier César Mejía-Gómez, Melissa Tigert, Michelle Jacobson, Elizabeta Shprits, Alison K. Shea, Eleni Philippopoulos, Joanne Kotsopoulos, Adam Bridger, Nichole Sanchez Diaz, Pugaliya Puveendrakumaran et al. · 2026 · Climacteric
  39. Histological Microstructure and In Vitro Mechanical Properties of Postmenopausal Ewe Perineal Body With and Without Estrogen Replacement Therapy
    Petra Kochová, Lucie Hajkova Hympanova, Kateřina Macková, Robert Cimrman, Zbyněk Tonar, Jan A. Deprest, Vladimír Kališ · 2026 · International Urogynecology Journal
  40. Sex Differences in the Protective Effect of Brain Volume: Age Attenuates Protection in Women
    Javier Gomez-Farias, Ngoc Mai Le, Joseph N. Samaha, Bruna Kfoury, Hussain Azeem, Ritesh Bajaj, Mahnoor Khalid, Freya Kanakhara, Shikha Tripathi, Shayan Shams et al. · 2026 · Stroke Vascular and Interventional Neurology
  41. Obesity treatment for postmenopausal women: Established therapies and emerging approaches - a narrative review
    Michał Kunicki, Zuzanna Katulska, Wiktoria Wolert, Anita Kunicka · 2026 · Maturitas
  42. Cardiovascular disease in women
    Kathryn M. Rexrode · 2026 · Elsevier eBooks
  43. Management of menopausal symptoms
    Jaya M. Mehta, Shari S. Bassuk, JoAnn Elisabeth Manson · 2026 · Elsevier eBooks
  44. Mechanistic redundancy and hierarchy of aging mechanisms: implications for strategies to extend healthspan and biomarker integration
    Maria Shvedova · 2026 · Frontiers in Aging
  45. The Cardiovascular Benefit of Menopausal Hormone Treatment is Age-Dependent in Ldlr −/− Mice
    Cassandra D. Lalisan, Connor Gavin, Bridget Litts, Min Zhong, Jeffrey A. Rein, Julia An, Rajguru Boobalan, Yu Wang, Amelia Van Aelst, Sivaprakasam Chinnarasu et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Optimizing estradiol serum levels for optimal skeletal and cardiovascular health during transdermal menopausal hormone therapy
    Paul Charles M. Piette, James A. Simon · 2026 · Gynecological Endocrinology
  47. Examining Aging Related Female Adiposity Through the Endocrine Lens
    Mert Ruşen Gülşen, Lubna Pal, Sanam Lathief · 2026 · Healthy ageing and longevity
  48. Microalgal Unsaponifiable Matter Ameliorates Estrogen Deficiency‐Induced Metabolic Dysfunction Through Intestinal Barrier Restoration and Gut Microbiota Modulation
    Seoyeon Chae, E J Jeong, Jin Woo Kim, Sunhye Lee · 2026 · Molecular Nutrition & Food Research
  49. Modeling cardiovascular risk across the menopause transition: a synthetic cohort study
    Alexandre Vallée · 2026 · Menopause The Journal of The North American Menopause Society
  50. Letter: Menopausal Status May Further Refine the Association Between the Atherogenic Index of Plasma and Abdominal Aortic Calcification in Women
    Hanxue Fu, Jiaoying Lou · 2026 · Angiology
  51. INTEGRANDO CINCO ALAVANCAS BASEADAS EM EVIDÊNCIAS EM UM MODELO ESTRUTURADO E MONITORADO LONGITUDINALMENTE PARA A MEDICINA DA OBESIDADE E DA COMPOSIÇÃO CORPORAL: UMA REVISÃO NARRATIVA
    Lucas Chinellato de Lima Pereira · 2026 · Revista de Geopolítica
  52. Cardiovascular Effects of Sex Hormones and Their Receptors
    Laura Molezini, Wenhan Xia, Raouf A. Khalil · 2026 · Physiology in health and disease
  53. Cardiovascular Disease Risk Factors Across Reproductive Transitions: From Menarche to Menopause
    Yamnia I. Cortés, Samar R. El Khoudary, JoAnn Elisabeth Manson · 2026 · Physiology in health and disease
  54. Long-term systemic outcomes of postmenopausal hormone replacement therapy by age at menopause: a real-world cohort study
    Ting-Fang Lu, Chien‐Hsing Lu, Yu‐Hsiang Shih, Yen‐Fu Chen, Chun-Ting Fan, Shao-Jing Wang, Shih‐Tien Hsu, Chih-Ku Liu, Lou Sun, Sheau-Feng Hwang et al. · 2026 · Human Reproduction Open
  55. Aging is associated with altered estrogen receptor expression and alters redox protein balance in human female skeletal muscle
    Andrea Tamariz‐Ellemann, Line Boel Nørregaard, Mikkel Oxfeldt, Line Barner Dalgaard, Susana Novella, Mette Hansen, Ylva Hellsten, Lasse Gliemann · 2026 · GeroScience
  56. Management of menopausal hormone therapy
    Julia Switzer, Lindsey Vignali, Jonathan D. Vignali, Rebecca Jackson · 2026 · Current Opinion in Obstetrics & Gynecology
  57. Data-driven insights in menopause: A scoping review of sensors and AI
    Hacer Kuduz, Fatma Vildan Engin, Yunus Çelik, Fırat Kaçar, Jason Moore, Alan Godfrey · 2026 · Maturitas
  58. Role of menopause in the development of cardiovascular disease in women
    Sophia Das, Wanqi Wang, Vijay Kunadian · 2026 · Open Heart
  59. Estrogen deficiency-induced lipid dysregulation in menopause: Mechanisms, metabolic consequences, and therapeutic strategies
    Alfi Sophian · 2026 · The Journal of Steroid Biochemistry and Molecular Biology
  60. Nature’s estrogen: Dioscorea and the emerging potential of β-selective estrogen receptor modulation in menopause
    Suman Halder, Devlina Pal, Abu Safana Biswas, Soumita Goswami, Srijeeta Hazra, Vivek Barık, Sipra Banerjee, Avishek Mandal, Suraj Sharma, Sweet Naskar · 2026 · Food and Humanity
  61. Geroprotective Effects of Drugs Modulating Metabolic Pathways: Perspectives of Pharmacology in Anti-Aging Therapy
    Marta Grycan, Rafał Zyśk, Gabriela Grycan, Grzegorz Jakiel, Alicja Dudek, Grażyna Gromadzka · 2026 · International Journal of Molecular Sciences
  62. Menopause as a Window of Opportunity: How Far Can Hormone Therapy Take Prevention?
    Ji Yeon Han · 2026 · Journal of Menopausal Medicine
  63. Menopausal Hormone Therapy and Cardiovascular Risk: Current Evidence and Treatment Recommendations
    Ashwin A. Pillai, Aryan Mehta, Shea‐Lee Godin, William H. Frishman, Wilbert S. Aronow · 2026 · Cardiology in Review
  64. Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women With Vasomotor Symptoms
    Ziyuan Wang, Sonja A. Swanson, Maria M. Brooks, Emma J.W. Barinas-Mitchell, Marnie H. Bertolet, Jared W. Magnani, Rebecca C. Thurston, Samar R. El Khoudary · 2026 · JAMA Internal Medicine
  65. Menopausal Hormone Therapy and Cardiovascular—Laying the Foundation for Future Trials
    Regina Castaneda, Stephanie S. Faubion · 2026 · JAMA Internal Medicine
  66. From PCOS to PMOS: An EMAS clinical guide to the proposed terminology and its relevance to menopause care
    Fatih Aktöz, C. Tamer Erel, İpek Betül Özçivit Erkan, Eleni Armeni, Judith Boban, Iuliana Ceauşu, Dorenda van Dijken, Timothy Hillard, Angelica Lindén Hirschberg, Ludwig Kiesel et al. · 2026 · Maturitas
  67. Relations of Menopause Timing With Pressure Pulsatility in the Framingham Study
    Amy Y. Habib, Ross A. Okazaki, Brenton R. Prescott, Vanessa Xanthakis, Leroy Leon Cooper, Connie W. Tsao, Emelia J. Benjamin, Ramachandran Srini Vasan, Naomi M. Hamburg, Gary F. Mitchell · 2026 · Hypertension
  68. Menopause Hormone Therapy in Women With Cardiovascular Risk Factors or Established Ischemic Heart Disease: A Joint FIGO and WHF Position Paper
    Chiara Benedetto, Martha Gulati, Suvarna Satish Khadilkar, Angela H.E.M. Maas, Federica Frezet, Gláucia Maria Moraes de Oliveira, Andrea Ricardo Genazzani, Hema Divakar, Athena Poppas · 2026 · Global Heart
  69. Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper
    Chiara Benedetto, Martha Gulati, Suvarna Satish Khadilkar, Angela H.E.M. Maas, Federica Frezet, Gláucia Maria Moraes de Oliveira, Andrea Ricardo Genazzani, Hema Divakar, Athena Poppas, the World Heart Federation (WHF) and the International Federation of Gynecology and Obstetrics (FIGO) · 2026 · International Journal of Gynecology & Obstetrics
  70. Reframing menopause and menopause hormone therapy as opportunities for healthy aging
    Laura L. Gravelsins, Mateja Perović, Madeline Wood Alexander, Tallinn F. L. Splinter, Andrew J. McGovern, Jennifer S. Rabin, Liisa A.M. Galea · 2026 · Science
  71. Peri- und Postmenopause: aktuelle diagnostische und therapeutische Aspekte für die DACH-Region
    Bettina Toth, Johannes Ott, Doris Maria Gruber, Gert Naumann, Susanna Weidlinger, Katrin Schaudig · 2026 · Wiener klinische Wochenschrift
  72. РОЛЬ РЕЦЕПТОРОВ ЭСТРОГЕНОВ В ПРОЦЕССАХ ВОЗРАСТНЫХ АРТЕРИАЛЬНЫХ ИЗМЕНЕНИЙ
    И.З. Зинеби, А.Б. Бажи, Н.Н. Максимюк, Ф.Д. Хусейнаева · 2026 · International Journal of Applied and Fundamental Research (Международный журнал прикладных и фундаментальных исследований)
  73. Plant-derived nutrition and perimenopausal emotional health: current evidence and research priorities
    Zhirui Sun, Xue Liu, Shuyue Dong, Qun Liu, Kun Wu, Xinyue Zhang, Zi Ye, 文薏, Maoya Li, Shaobin Wei · 2026 · Frontiers in Nutrition
  74. Reappraising the safety of menopausal hormone therapy for women—implications for the clinic
    Angelica Lindén Hirschberg · 2026 · The Journal of Clinical Endocrinology & Metabolism
  75. Revisiting menopausal hormone therapy for bone health: evidence, controversies, and clinical positioning in India in 2026
    Nupoor Vaghasia, Lakshmi Nagendra, Nitin Kapoor, Aasim Maldar, Abhamoni Baro, Akhila Panduranga Bhandarkar, Ameya Joshi, Amritava Ghosh, Ana S. Monteiro, Aneez Joseph et al. · 2026 · Archives of Osteoporosis